Literature DB >> 3595677

Increase in cis-dichlorodiammineplatinum (II) cytotoxicity upon reversible electropermeabilization of the plasma membrane in cultured human NHIK 3025 cells.

J E Melvik, E O Pettersen, P B Gordon, P O Seglen.   

Abstract

A series of brief electrical high-voltage discharges were given to cultured NHIK 3025 cells to render the plasma membrane transiently permeable to drugs. Using [14C]sucrose as an inert marker which normally does not cross plasma membranes, increased permeability could be demonstrated for no longer than 10 min following electrical treatment, indicating that the permeabilization was entirely reversible. The reversibility of the treatment was further demonstrated by a lack of effect on cell growth and colony-forming ability. When cells were given electrical discharges immediately before or during exposure to cis-dichlorodiammineplatinum(II)(cis-DDP) the cytotoxic drug effect increased. By using electrical discharges during a 2 hr drug treatment period the cytotoxicity was enhanced to an extent corresponding to at least a 3-fold increase in drug uptake relative to unpermeabilized cells. This increase in drug uptake was confirmed by direct measurements of the amount of cell-associated Pt by atomic absorbtion spectroscopy. The results suggest that uptake across the plasma membrane may be the rate-limiting factor in the cytotoxic effect of cis-DDP. Furthermore, the methodology applied in the present study may prove useful in assessing the influence of membrane permeability on the effect of other cytotoxic drugs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3595677     DOI: 10.1016/0277-5379(86)90090-8

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  10 in total

1.  Electrochemotherapy for colorectal cancer with commonly used chemotherapeutic agents in a mouse model.

Authors:  S Kuriyama; M Matsumoto; A Mitoro; H Tsujinoue; T Nakatani; H Fukui; T Tsujii
Journal:  Dig Dis Sci       Date:  2000-08       Impact factor: 3.199

2.  An in vitro test for measuring cytotoxicity of mercuric chloride to human kidney epithelial cells by specific enzyme release.

Authors:  D Merlet; M Mellado; J P Merlet; J Cambar
Journal:  Cytotechnology       Date:  1988-07       Impact factor: 2.058

3.  2-NBDG, a fluorescent analogue of glucose, as a marker for detecting cell electropermeabilization in vitro.

Authors:  Elham Raeisi; Lluis M Mir
Journal:  J Membr Biol       Date:  2012-08-11       Impact factor: 1.843

4.  In vitro interaction of lithotripter shock waves and cytotoxic drugs.

Authors:  S Gambihler; M Delius
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

Review 5.  Cellular accumulation of the anticancer agent cisplatin: a review.

Authors:  D P Gately; S B Howell
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

6.  The combined effects of high-energy shock waves and cytostatic drugs or cytokines on human bladder cancer cells.

Authors:  K Wörle; P Steinbach; F Hofstädter
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

7.  Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin.

Authors:  M Cemazar; D Miklavcic; J Scancar; V Dolzan; R Golouh; G Sersa
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

8.  Uncertainty Quantification in Irreversible Electroporation Simulations.

Authors:  Nicholas Labarbera
Journal:  Bioengineering (Basel)       Date:  2017-05-06

9.  The antitumor efficiency of combined electrochemotherapy and single dose irradiation on a breast cancer tumor model.

Authors:  Elham Raeisi; Seyed Mahmoud Reza Aghamiri; Azin Bandi; Negar Rahmatpour; Seyed Mohammad Firoozabadi; Sedigheh Amini Kafi-Abad; Lluis M Mir
Journal:  Radiol Oncol       Date:  2012-06-19       Impact factor: 2.991

10.  The binding of cis-dichlorodiammineplatinum(II) to extracellular and intracellular compounds in relation to drug uptake and cytotoxicity in vitro.

Authors:  J E Melvik; J M Dornish; E O Pettersen
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.